Stock Evaluator: BrainsWay Ltd. (BWAY)

BrainsWay Ltd. BWAY

$9.11 -0.28 -2.98%
November 17, 2026 4:00:00 PM EST November 10, 2021 Volume: 153,852
After Hours: $120.37   0.15  |  0.12% November 10, 2021 7:59 PM EST Volume: 72,713
USD NASD | DELAYED PRICE
SECTOR INDUSTRY
Health Care Health Care Equipment & Supplies

A+ Stock Grade Summary:

VALUE:
GROWTH:
MOMENTUM:
EPS REVISIONS:
QUALITY:
COMPANY SUMMARY
BrainsWay Ltd. develops and sells noninvasive neurostimulation treatments for mental health disorders in the United States and internationally. It offers Deep Transcranial Magnetic Stimulation platform technology for the treatment of major depressive disorders, anxious and late-life depression, obsessive-compulsive disorders, smoking addiction, bipolar disorders, post-traumatic stress disorders, schizophrenia, Alzheimer’s disease, autism, chronic pain, multiple sclerosis, post stroke rehabilitation, and Parkinson’s diseases. The company serves doctors, hospitals, and medical centers in the field of psychiatry. The company was founded in 2003 and is headquartered in Jerusalem, Israel.

Commentary & Analysis


Financial Summary

Share Statistics BWAY Industry
Median
Percentile
(All Stocks)
Market Cap (Mil) $372.7 $372.7 35%
Shares Out (Mil) 38.7 41.4 41%
Institutional Ownership 66.9% 84.0% 41%
Float (Mil) 24.2 35.6 32%
Beta 0.08 0.87 7%
Avg Daily Volume (000s) 185 323 43%
Price Change
(52-week)
15.6% 57.5% 67%
Growth BWAY Industry
Median
Percentile
(All Stocks)
Sales (5yr) 18.8% 11.8% 79%
Net Income (5yr) 27.8% (5.7%) 83%
EPS (5yr) 22.5% 10.6% 72
Dividends (5yr) 0.0% 0.0% 0%
Cash Flow (5yr) 28.2% (15.8%) 85%
Estimates Qtrly Current
Fiscal
Year
Next
Fiscal
Year
# of Estimates 2 2 3
Current EPS $0.070 $0.250 $0.500
Month Ago EPS $0.093 $0.307 $0.507
# Rev Up 2 0 2
# Rev Down 0 1 0
Three Months Ago EPS $0.075 $0.270 $0.487
Year/Year Chg 2.9% 37.4% 191.2%
Financials BWAY Industry
Median
Percentile
(All Stocks)
Sales (TTM) (Mil) $61 $125 21%
Net Income (TTM) (Mil) $9 ($9) 44%
EPS (TTM) $0.243 ($0.300) 47%
Operating Cash Flow (TTM) (Mil) $8 ($1) 37%
Net Cash Flow (TTM) (Mil) $-0 $2 43%
Long-Term Debt (Q1) (Mil) $6 $21 25%
Enterprise Value (Q1) (Mil) $476 $381 34%
Valuation BWAY Industry
Median
Percentile
(All Stocks)
P/B 4.62 2.58 80%
P/E 39.8 25.8 82%
Dividend Yield 0.0% 0.0% 0%
PEG (5yr hist) 1.8 1.3 67%
Ratios BWAY Industry
Median
Percentile
(All Stocks)
Gross Margin 75.3% 59.5% 85%
Net Margin 15.6% (4.5%) 73%
ROA 8.7% (10.1%) 84%
ROE 13.3% (8.3%) 66%
Liabilities to Assets 35.1% 45.8% 26%
F-Score 5 4 50%

BrainsWay Ltd. did not pass any screens on 11/17/2026.

Price and market data provided by QuoteMedia and delayed a minimum of 15 minutes unless otherwise indicated. Fundamental data provided by AAII's Stock Investor Pro and S&P Global Market Intelligence and are updated through the previous trading day.

Ⓒ 2026 American Association of Individual Investors